ENOB insider filings
Enochian Biosciences Inc — 44 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-08-01. Screen ENOB transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for ENOB between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Enochian Biosciences Inc
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-08-01 | 4 | Sindlev Rene — Director, 10% owner | Grant/award (A): 131,579 (derivative) @ $0 | EDGAR |
| 2023-06-27 | 4 | Sindlev Rene — Director, 10% owner | Grant/award (A): 1,886,794 @ $0.53 · Grant/award (A): 943,397 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | McNicol Jayne — Director | Grant/award (A): 79,787 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | SAPIRSTEIN JAMES — Director | Grant/award (A): 64,655 (derivative) @ $0 | EDGAR |
| 2023-03-21 | 4 | Sindlev Rene — Director, 10% owner | Grant/award (A): 877,193 @ $1.14 · Grant/award (A): 438,597 (derivative) @ $0 | EDGAR |
| 2023-02-06 | 4 | William Anderson Wittekind — 10% owner | Other (J): 1,216,467 | EDGAR |
| 2023-02-06 | 4 | William Anderson Wittekind — 10% owner | Other (J): 97,032 | EDGAR |
| 2023-02-06 | 4 | Weird Science LLC — 10% owner | Other (J): 17,545,283 · Other (J): 1,268,880 · Other (J): 3,631,234 · Other (J): 17,545,283 · Other (J): 61,249 · Other (J): 97,032 · +2 more | EDGAR |
| 2023-02-06 | 4/A | William Anderson Wittekind — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2023-01-05 | 4 | Brosgart Carol L — Director | Grant/award (A): 57,252 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Alton Gregg H — Director | Grant/award (A): 57,252 (derivative) @ $0 | EDGAR |
| 2022-10-27 | 4 | Binette Francois — Executive VP for R&D | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2022-10-27 | 4 | Puche Luisa — Chief Financial Officer | Grant/award (A): 80,000 (derivative) @ $0 | EDGAR |
| 2022-10-26 | 4 | Gronfeldt-Sorensen Henrik — Director | Grant/award (A): 45,455 (derivative) @ $0 | EDGAR |
| 2022-10-25 | 4 | Sindlev Rene — Director, 10% owner | Grant/award (A): 32,609 (derivative) @ $0 | EDGAR |
| 2022-09-15 | 4 | Dybul Mark — Chief Executive Officer, Director | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2022-08-03 | 4 | Sandler Carl Forest | Other (J): 3,969,090 @ $0 · Other (J): 992,273 @ $0 | EDGAR |
| 2022-07-26 | 4 | Puche Luisa — Chief Financial Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2022-07-18 | 4 | Sindlev Rene — Director, 10% owner | Other (J): 125,000 · Other (J): 128,493 | EDGAR |
| 2022-06-13 | 4 | McNicol Jayne — Director | Grant/award (A): 16,892 (derivative) @ $0 | EDGAR |
| 2022-05-20 | 4 | Gumrukcu Serhat — 10% owner | Sale (S): 125,000 @ $8 · Sale (S): 128,493 @ $8 | EDGAR |
| 2022-05-20 | 4 | Sindlev Rene — Director, 10% owner | Purchase (P): 125,000 @ $8 · Purchase (P): 128,493 @ $8 | EDGAR |
| 2022-03-24 | 4 | Sandler Carl Forest — Director, 10% owner | Sale (S): 1,927 @ $9.06 | EDGAR |
| 2022-02-23 | 4 | Sandler Carl Forest — Director, 10% owner | Sale (S): 6,792 @ $9.03 · Sale (S): 6 @ $9 | EDGAR |
| 2022-01-11 | 4/A | Puche Luisa — Chief Financial Officer | Disposition to issuer (D): 10,000 @ $0 · Grant/award (A): 16,266 @ $0 | EDGAR |
| 2022-01-07 | 4 | Sandler Carl Forest — Director, 10% owner | Gift (G): 2,500 @ $0 · Gift (G): 1,500 @ $0 · Gift (G): 1,500 @ $0 | EDGAR |
| 2022-01-04 | 4 | Gronfeldt-Sorensen Henrik — Director | Grant/award (A): 3,646 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4 | Sindlev Rene — Director, 10% owner | Grant/award (A): 3,646 (derivative) @ $0 | EDGAR |
| 2022-01-04 | 4/A | Gronfeldt-Sorensen Henrik — Director | Grant/award (A): 10,519 (derivative) @ $0 | EDGAR |
| 2022-01-03 | 4 | Brosgart Carol L — Director | Grant/award (A): 9,458 (derivative) @ $0 | EDGAR |
| 2021-12-28 | 4 | Alton Gregg H — Director | Grant/award (A): 9,458 (derivative) @ $0 | EDGAR |
| 2021-12-22 | 4 | Sindlev Rene — Director, 10% owner | Grant/award (A): 9,036 (derivative) @ $0 | EDGAR |
| 2021-12-22 | 4 | Sandler Carl Forest Jr — Director, 10% owner | Grant/award (A): 12,712 (derivative) @ $0 | EDGAR |
| 2021-12-22 | 4 | Gronfeldt-Sorensen Henrik — Director | Grant/award (A): 10,519 (derivative) @ $0 | EDGAR |
| 2021-12-22 | 4 | Alton Gregg H — Director | Grant/award (A): 25,424 (derivative) @ $0 · Grant/award (A): 15,625 (derivative) @ $0 | EDGAR |
| 2021-12-21 | 4 | Brosgart Carol L — Director | Grant/award (A): 25,424 (derivative) @ $0 · Grant/award (A): 15,625 (derivative) @ $0 | EDGAR |
| 2021-12-20 | 4 | Puche Luisa — Chief Financial Officer | Grant/award (A): 16,266 (derivative) @ $7.75 · Other (J): 15,000 (derivative) @ $6.15 | EDGAR |
| 2021-11-23 | 4 | Puche Luisa — Chief Financial Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2021-07-22 | 4 | Dybul Mark — Chief Executive Officer, Director | Grant/award (A): 2,000,000 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | McNicol Jayne — Director | Grant/award (A): 26,498 (derivative) @ $0 | EDGAR |
| 2021-03-11 | 4 | SAPIRSTEIN JAMES — Director | Grant/award (A): 19,894 (derivative) @ $0 | EDGAR |
| 2021-03-11 | 4 | D An Evelyn — Director | Grant/award (A): 19,894 (derivative) @ $0 | EDGAR |
| 2020-12-16 | 4 | Dybul Mark — Executive Vice Chair, Director | Other (J): 180 @ $0 | EDGAR |
| 2020-12-16 | 4 | Sandler Carl Forest Jr — Director, 10% owner William Anderson Wittekind — 10% owner | Other (J): 61,249 @ $0 | EDGAR |
Recent 8-K events — Enochian Biosciences Inc
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-09 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-17 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-11 | 8-K/A | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-05-01 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.01 — Completion of Acquisition or Disposition of Assets 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ENOB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs